Safety and Tolerability of NOX66 in Combination With Palliative Radiotherapy in Patients With Late-Stage Prostate Cancer

NCT03307629 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Cancer

Interventions

DRUG: NOX66
RADIATION: Irradiation Therapy

Sponsor

Noxopharm Limited